Matthew Rabinowitz (@mattrverse) 's Twitter Profile
Matthew Rabinowitz

@mattrverse

BioTech, AI Security, Founder & investor @NateraGenetics, @MyOmeinc, @NatureEye, Marble Therapeutics | R&D Leader of the Year 2024

ID: 1518848740085354496

calendar_today26-04-2022 07:06:16

105 Tweet

774 Followers

41 Following

MyOme (@myomeinc) 's Twitter Profile Photo

Excited to be announce our Rare Disease Diagnostic Portfolio—powered by whole genome sequencing to transform rare disease testing. Learn more: lnkd.in/gKcXcTze

Excited to be announce our Rare Disease Diagnostic Portfolio—powered by whole genome sequencing to transform rare disease testing. Learn more:  lnkd.in/gKcXcTze
Matthew Rabinowitz (@mattrverse) 's Twitter Profile Photo

.Natera Signatera test nailed sarcoma recurrence with 89% sensitivity and 100% specificity. Check out this Stanford-led study proving personalized ctDNA is the future of cancer care. natera.com/company/news/l…

Matthew Rabinowitz (@mattrverse) 's Twitter Profile Photo

Why does such basic common sense seem like poetry. If this message from David Keyes baffles you, you'll find an explanation in that Qatar spends more on US lobbying than anybody else outside the US. US leaders, stop being puppets of the Qatari regime and wake up!

Matthew Rabinowitz (@mattrverse) 's Twitter Profile Photo

Hahaha. If you need another reason to want Hamas obliterated. Although Yuval Raphael did sing beautifully. For those who don't know, she survived the Nova massacre by hiding for 8 hours, with shrapnel injuries, under 40 dead bodies in a bomb shelter. Can you imagine coming from

Natera (@nateragenetics) 's Twitter Profile Photo

ASCO is one of the most important oncology meetings of the year, and together with our collaborators, Natera will share Signatera data from 25+ presentations across 10 different types of cancer. This includes: • Breast cancer: 8 accepted abstracts (4 oral presentations) •

ASCO is one of the most important oncology meetings of the year, and together with our collaborators, Natera will share Signatera data from 25+ presentations across 10 different types of cancer. This includes:  

• Breast cancer: 8 accepted abstracts (4 oral presentations)  
•
Matthew Rabinowitz (@mattrverse) 's Twitter Profile Photo

You would have thought they'd learn from the Vichy government in France. Macron, Starmer, Carney please rethink your effective collaboration with Hamas and global jihadism. This time, it's not clear the US will save your countries from conquest by monsters.

VA Salt Lake City (@vasaltlakecity) 's Twitter Profile Photo

Big thanks to Natera for donating these care kits to Veterans who were staying at our hospital over the Memorial Day weekend. Today and every day we remember those who made the ultimate sacrifice for this country!

Big thanks to <a href="/NateraGenetics/">Natera</a> for donating these care kits to Veterans who were staying at our hospital over the Memorial Day weekend. Today and every day we remember those who made the ultimate sacrifice for this country!
Matthew Rabinowitz (@mattrverse) 's Twitter Profile Photo

Haha. Quite pleasant to watch. But arguments happen. What's illustrative is how Macron instinctively and brazenly chooses to lie and say they were joking around.

Natera (@nateragenetics) 's Twitter Profile Photo

Learn more about Signatera and the foundational technology that is transforming care for patients with cancer. Hear directly from Natera CEO Steve Chapman on how Signatera can detect molecular residual disease and help determine whether therapy is working. #CancerCare

Natera (@nateragenetics) 's Twitter Profile Photo

What an incredible #ASCO25! We were thrilled to connect with everyone who came through our booth and want to thank the Naterans on our team for their hard work in making it a special event. Thank you to Marla Lipsyc-Sharf, MD, Julia Foldi, MD, PhD and Mridula George, MD

What an incredible #ASCO25! We were thrilled to connect with everyone who came through our booth and want to thank the Naterans on our team for their hard work in making it a special event.

Thank you to Marla Lipsyc-Sharf, MD, Julia Foldi, MD, PhD and Mridula George, MD
Matthew Rabinowitz (@mattrverse) 's Twitter Profile Photo

Medicare now covers Signatera Genome—Natera' MRD test leveraging a full genome sequence of the tumor and germline. This week at #ASCO: new data from 392 patients shows the power of Signatera Genome, built on our mPCR-NGS tech that allows deep sequencing of high-quality

Matthew Rabinowitz (@mattrverse) 's Twitter Profile Photo

God speed to the brave Israeli fighter pilots. Thank you on behalf of all societies that stand apart from death cults and who fear nuclear war. Churchill's words are true again: "Never was so much owed by so many to so few."